Skip to Main Content

Paper Details

Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL-HBV and REVEAL-HCV cohort studies.
Int J Cancer
2
2023
CD14, Cancer, Gut barrier dysfunction, HBV-related HCC, HBV-related or HCV-related HCC, HCC, HCV, IgA, IgG, IgM, LBP, LPS coreceptor, LPS-binding protein, Liver Disease, antiflagellin IgA, cirrhosis, flagellin, gut, gut barrier dysfunction, hepatitis, hepatitis B or C viral, hepatocellular carcinoma, immunoglobulin A, liver cancer, liver diseases
Author NameAffiliation
Ruth M PfeifferNational Cancer Institute
Ruth M PfeifferNational Cancer Institute
  • 1 - 2

Datasets

Release 1.2